HSN CARE (HAIR, SKIN AND NAILS COMPLEX)
Food supplement declared in France, declaration No 2021-6-775
HSN CARE (HAIR, SKIN AND NAILS COMPLEX), from HARRISON SPORT NUTRITION, S.L., is a food supplement declared in France. Status: withdrawn from the market on 12 April 2026. Main ingredients: Equisetum arvense 100 mg per day, Bambusa vulgaris 42.8 mg per day, Haematococcus pluvialis 2 mg per day, Piper nigrum 2 mg per day, Pantothenic acid (vitamin B5). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- HSN
- Food business operator placing the product on the market
- HARRISON SPORT NUTRITION, S.L.
- Status
- Withdrawn from the market on 12 April 2026
- Form
- Capsule
- Daily dose
- 2 capsules
- Objectives stated by the manufacturer (these are not authorised claims)
- Skin, Hair and nails
Declaration 225752, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Equisetum arvense L. | Parties aériennes | Extrait sec hydroalcoolique | 100 mg |
| Bambusa vulgaris Schrad. | Tige | Extrait sec hydroalcoolique | 42.8 mg |
| Haematococcus pluvialis Flotow | Plante entière | Poudre (de plantes séchées ou broyées) | 2 mg |
| Piper nigrum L. | Fruit | Extrait sec hydroalcoolique | 2 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Acide hyaluronique | not declared |
| Ubiquinone | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| beta-carotene | β-Carotene | no limit (insufficient data) | no fixed dose |
| copper bisglycinate | Copper | 5,000 µg | 2,000 µg |
| ferrous bisglycinate | Iron | 40 mg (safe level) | 14 mg |
| ferrous sulphate | Iron | 40 mg (safe level) | 14 mg |
| pteroylmonoglutamic acid | Folate (vitamin B9) | 1,000 µg | 200 µg |
| potassium iodide | Iodine | 600 µg | 150 µg |
| nicotinamide | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
| choline-stabilised orthosilicic acid | Silicon | no limit (insufficient data) | no fixed dose |
| L-selenomethionine | Selenium | 255 µg | 50 µg |
| methylcobalamin | Vitamin B12 | no adverse effect defined | dose annulled by the French Council of State in 2011 |
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
| L-ascorbyl 6-palmitate | Vitamin C | no limit (insufficient data) | 180 mg |
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
| D-alpha-tocopheryl acid succinate | Vitamin E | 300 mg | 30 mg |
| DL-alpha-tocopherol | Vitamin E | 300 mg | 30 mg |
| zinc bisglycinate | Zinc | 25 mg | 15 mg |
Additives
E464, E341, E470b, E551
Other ingredients
maltodextrine, amidon de maïs
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux personnes souffrant de maladies entraînant une accumulation anormale de fer (hémochromatose, polyglobulie...). Non recommandé aux personnes souffrant de troubles de la thyroïde. Le bêta-carotène n'est pas recommandé aux fumeurs. Si vous êtes enceinte ou si vous allaitez, contactez un professionnel de la santé avant de prendre tout complément.
Regulatory points
- Information
Withdrawn from the market on 12 April 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Haematococcus pluvialis Flotow
Read the warning, when it applies and the studies cited
Haematococcus pluvialis extract
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Eye strain, Eye fatigue.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : HSN
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “HSN CARE (HAIR, SKIN AND NAILS COMPLEX): composition and regulation”, https://compoatlas.com/en/supplements/products/225752-hsn-care-hair-skin-and-nails-complex, updated 15 November 2026.